BioMed Realty Trust, Inc. (NYSE: BMR) reported Q4 EPS of $0.28, $0.01 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $112.4 million versus the consensus estimate of $112.02 million.

For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.

Earnings